Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for RIPRETINIB
- A Study of DCC-3116 in Combination With Anticancer Therapies in Participants With Advanced Malignancies
- Rivoceranib Plus Paclitaxel in Patients With Gastrointestinal Stromal Tumor
- A Phase 3 Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib
- A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
- Ripretinib Used for Resectable Metastatic GIST After Failure of Imatinib Therapy
- Ripretinib in Combination With Binimetinib in Patients With Gastrointestinal Stromal Tumor (GIST)
- A Study to Assess the Efficacy and Safety of DCC-2618 and Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumors After Treatment With Imatinib
- A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients With Advanced GIST
- A Study of DCC-2618 (Ripretinib) Evaluating Efficacy, Safety, and Pharmacokinetics In Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
- A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib
- Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies
- A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies
Clinical trials list
click for details